Your search for proton pump inhibitor returned 120 results

Findings showed that children who were initiated on PPIs were 57% more likely to be diagnosed with asthma.

The case involved a 32-year-old male who was prescribed pantoprazole after initially presenting with dyspepsia-like symptoms.

The authors found that compared to the use of H2RA therapy, patients initiated on PPI therapy had a 25% increased risk of death (hazard ratio [HR] 1.25, 95% CI: 1.23-1.28).

Patients who are taking proton pump inhibitors (PPIs) may be at increased risk for kidney function decline, chronic kidney disease (CKD), and kidney failure.

The FDA has issued a warning that the use of proton pump inhibitors (PPIs) may be associated with an increased risk of Clostridium difficile-associated diarrhea (CDAD).

Several treatments were attempted but failed to manage the patient’s conditions, including proton pump inhibitors, topical steroids, a restricted diet, and infliximab (3 doses) for arthritis.

Konvomep contains 2mg of omeprazole, a proton pump inhibitor, and 84mg of sodium bicarbonate per mL after reconstitution.

A recent report describes the case of a 47-year-old male patient who experienced eosinophilic gastritis secondary to proton pump inhibitor (PPI) administration and highlights the importance of increasing awareness of this potential hypersensitivity reaction.

According to the results of a retrospective cohort study, male patients who utilize proton pump inhibitors (PPIs) appear to be at increased risk of developing gynecomastia.

To identify trends in gastric acid suppressant use, researchers analyzed data from the National Ambulatory Medical Care Survey. They classified any outpatient visit with a documented prescription for a proton pump inhibitor or histamine-2 receptor antagonist as a gastric acid suppressant use.